Bowel Management Systems - Market Insights, Competitive Landscape and Market Forecast-2027

Bowel Management Systems Market By Product Type ( Devices [Irrigation Systems, Nerve Modulation Devices, Others] Accessories), By Patient Type (Adult And Pediatrics), By End-User (Hospitals, Ambulatory Surgical Centres, And Home Care), and by geography is projected to expand at a noteworthy CAGR forecast till 2027 owing to the growing burden of aging population, worldwide and rising neurological disorders

The global bowel management systems market was valued at USD 1.48 billion in 2021, growing at a CAGR of 3.98% during the forecast period from 2022 to 2027, in order to reach USD 1.87 billion by 2027. The increase in demand for bowel management products is primarily attributed to the increasing geriatric population across the globe who are more susceptible to developing bowel-associated disorders. In addition, rising neurological disorders such as Parkinson's disease, stroke, among others, and growing cases of nerve injuries due to spinal cord injuries, trauma injuries, and others would also increase the demand for bowel management systems as these factors most often lead to bowel incontinences. Also, rising government initiatives to raise awareness regarding prevention and management of bowel control issues, approval and launch of various bowel management products, among others are anticipated to bolster the market for bowel management systems during the forecasted period.

Bowel Management Systems Market Dynamics:

The market for bowel management systems is gaining pace at present due to the rising burden of the geriatric population who are prone to develop bowel disorders. This is because some people gradually lose muscle strength as they age. In addition, older women experience accidental bowel leakage more often as compared to men. According to the World Ageing Population 2020 Highlights, there were about 727 million people aged 65 years or over in the world in 2020. The report also projected the global number of older persons to double reaching over 1.5 billion in 2050. In addition, the report also mentioned that women accounted for about 55% of the older population aged 65 years or over in the same year.

Moreover, an increase in neurological disorders such as advanced dementia, multiple sclerosis, Parkinson's disease (PD), or nerve injuries due to spinal cord injuries, and others could also be potential factors that would increase the demand for bowel management systems as these are the significant risk factors for neurogenic bowel dysfunction. For instance, as per the Multiple Sclerosis International Federation 2020 data, approximately 2.8 million people were living with multiple sclerosis around the globe in the same year.

Additionally, rising cases of traumatic injuries due to road accidents, occupational accidents, and falls, among others could lead to peripheral nerve injuries thereby raising the demand for Bowel Management Systems products. For instance, according to the International Labour Organization (ILO) 2021 data, worldwide, there are approximately 340 million occupational accidents annually.

Hence, all the above-mentioned factors are expected to bolster the global market for Bowel Management Systems products.

Furthermore, approval of bowel management products would also augment the market for bowel management systems in the forthcoming years. For instance, on November 22, 2019, Dentsply Sirona received FDA approval for Navina Smart System and Navina Classic System intended for use in patients with neurogenic bowel dysfunction, fecal incontinence, and chronic constipation.

Thus, all the aforementioned factors are expected to propel the bowel management systems market.

However, the discomfort associated with the use of bowel management systems is likely to impede the market for bowel management systems.

With the unprecedented COVID-19 pandemic the demand for Bowel Management Systems products in the market decreased. This was due to the temporary suspension of numerous elective procedures and outpatient visits as the healthcare system guidelines worldwide temporarily focused all their efforts on the management of COVID-19 patient load during the initial lockdown period. Moreover, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains, including healthcare services, thereby paving the way for a sound period of recovery for the Bowel Management Systems market.

Bowel Management Systems Market Segment Analysis:

Bowel Management Systems Market By Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, Others] Accessories), By Patient Type (Adult and Pediatrics), By End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Bowel Management Systems product segment, the nerve modulation devices are anticipated to hold a significant market share during the forecasted period. This is owing to the increase in neurogenic bowel disorders due to an increase in cases of trauma to the brain, spinal cord, or peripheral nerves. For instance, according to the Spinal Cord Injuries Australia 2021, more than 15,000 Australians were living with a spinal cord injury in the same year out of which 46% are due to land transport crashes involving motor vehicle occupants and unprotected land transport users such as motorcyclists, pedestrians, pedal cyclists and quad bikes whereas falls contribute to 36% of spinal cord injuries.

Furthermore, the rising focus towards R&D activities by the government organization and manufacturing companies for the development of nerve modulation devices for the management of bowel disorders such as irritable bowel syndrome, accidental bowel leakage, and others are projected to contribute to the market growth.

For instance, NICHD (National Institute of Child Health and Human Development) Pelvic Floor Disorders Network has completed a clinical trial in the year 2020 for device ES-130, a neuromodulation device for accidental bowel leakage.

Moreover, an increase in product approval for nerve modulation bowel management devices will contribute to the market growth. For instance, in January 2020, Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of chronic pain of peripheral nerve origin, received CE mark approval for its StimRouter® Neuromodulation System indicated for the treatment of faecal incontinence (FI) across Europe.

Hence, all the interplay of all the above-mentioned factors will contribute to the segmental growth of the bowel management systems market in the upcoming years.

North America is expected to dominate the overall Bowel Management Systems Market:

Among all the regions, North America is expected to occupy a major share in the overall Bowel Management Systems market in the year 2020 and is expected to hold its position during the forecasted period. This domination is due to the rise in the target population in the region. In addition, an increase in neurological conditions, the presence of leading bowel management systems companies, and favourable reimbursement policies, among others are expected to surge the demand for the bowel management systems market.

The rising prevalence of Parkinson's disease in the region would contribute to the bowel management systems market. This is because faecal incontinence is a very debilitating symptom that can occur in advanced PD thereby leading to an increase in the demand for bowel management products. For instance, as per the Parkinson's Foundation 2022, approximately 1.2 million people in the US are estimated to suffer from Parkinson's disease by the year 2030.

In addition, as per the 2021 data published by Crohn's and Colitis Canada, Persons with Crohn's disease or ulcerative colitis (together, inflammatory bowel disease [IBD]) make up more than 0.75% of the Canadian population in 2021. The disease affects over 300,000 Canadians which is expected to rise to 400,000 (1% of the population) by 2030. Thus, the rising population with bowel dysfunction and neurological disorders who are susceptible to developing bowel disorders would contribute to the growth of the regional bowel management systems market.

Moreover, product approvals in the region for the treatment of bowel discomfort are also expected to bolster the demand for bowel management systems in the country. For instance, on September 06, 2019, Axonics Modulation Technologies, Inc. received FDA clearance for its Axonics Sacral Neuromodulation System indicated for the treatment of chronic faecal incontinence in patients who have failed or are not candidates for other treatments, such as medications or physical therapy.

Further, the Asia Pacific region has future potential for the bowel management systems market. This is predominantly owing to the rising geriatric population, growing patient pool, increase in government initiatives to raise awareness regarding the proper management of bowel-associated disorders, and others. For instance, as per the Continence Foundation of Australia 2021 data, by 2030 over 6.2 million Australians will be affected by bowel or bladder incontinence. Furthermore, the Australian Government supports prevention and management of incontinence through three initiatives: National Continence Program (NCP), Continence Aids Payment Scheme (CAPS), and Stoma Appliance Scheme. In addition, improving healthcare infrastructure, rising disposable income, among others also some of the factors responsible for bowel management systems market growth in the region during the forthcoming years.

Bowel Management Systems Market Key Players:

Some of the key market players operating in the Bowel Management Systems market include Coloplast Corp, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, ConvaTec Inc., Laborie., Consure Medical, Axonics, Inc., Renew Medical Inc, Hollister Incorporated, Welland Medical Limited., Wellspect HealthCare (Dentsply Sirona Company) Restech., Bioness, Inc., A.M.I. GmbH, ProSys International Ltd, Angiplast Pvt Ltd., Marlen Manufacturing & Development Company., among others.

Recent Developmental Activities in the Bowel Management Systems Market:

• In October 2021, Laborie Medical Technologies Corp. (Laborie) a specialist medical technology company, acquired Pelvalon, Inc., a privately-held medical device company located in Redwood City, CA which has developed an innovative product called the Eclipse™ System, a non-surgical, patient-controlled device for women suffering from faecal incontinence (FI).
• In May 2021, Axonics, Inc., a global medical technology company focused on developing and commercializing novel products for the treatment of bladder and bowel dysfunction, received European CE Mark approval for its second-generation Axonics r-SNM® implantable neurostimulator (INS) and wireless patient remote control with SmartMRI™ technology.
• In August 2020, Medtronic plc received approval from the US FDA for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads used for treating overactive bladder (OAB), faecal incontinence (FI), and non-obstructive urinary retention.

Key Takeaways from the Bowel Management Systems Market Report Study

• Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Bowel Management Systems market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Bowel Management Systems Market.
• Various opportunities available for the other competitor in the Bowel Management Systems Market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Bowel Management Systems market growth in the coming future?

Target Audience who can be benefited from the Bowel Management Systems Market Report Study

• Bowel Management Systems providers
• Research organizations and consulting companies
• Bowel Management Systems-related organization, association, forum, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders in Bowel Management Systems
• Various End-users want to know more about the Bowel Management Systems Market and the latest technological developments in the Bowel Management Systems market.

Frequently Asked Questions for the Bowel Management Systems Market:

1. What is Bowel Management Systems?

Bowel incontinence, also known as faecal incontinence is generally the situation when the patient is not able to control bowel movements which results in involuntary loss of solid or liquid stool. The clinical devices used to manage bowel activity are called bowel management systems.

2. What is the market for Global Bowel Management Systems?

The global bowel management systems market was valued at USD 1.48 billion in 2021, growing at a CAGR of 3.98% during the forecast period from 2022 to 2027, in order to reach USD 1.87 billion by 2027.

3. What are the drivers for the Global Bowel Management Systems?

The major factors driving the demand for Bowel Management Systems are the rising cases of nerve injuries, increase in the geriatric population, growing neurological disorders. In addition, rising government initiatives to raise awareness regarding bowel incontinence management and approval and launch of advanced products, among others are expected to drive the market.

4. What are the key players operating in Global Bowel Management Systems?

Some of the key market players operating in the Bowel Management Systems market include Coloplast Corp, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, ConvaTec Inc., Laborie., Consure Medical, Axonics, Inc., Renew Medical Inc, Hollister Incorporated, Welland Medical Limited., Wellspect HealthCare (Dentsply Sirona Company) Restech., Bioness, Inc., A.M.I. GmbH, ProSys International Ltd, Angiplast Pvt Ltd., Marlen Manufacturing & Development Company., among others.

5. Which region has the highest share in the Bowel Management Systems market?

Among all the regions, North America is expected to occupy a major share in the overall Bowel Management Systems market in the year 2021 and is expected to hold its position during the forecasted period. This domination is due to the rise in the target population in the region. In addition, an increase in neurological conditions, the presence of leading bowel management systems companies, and favourable reimbursement policies, among others are expected to surge the demand for the bowel management systems market.
This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.